Chronic Periodontitis and Alveolar Bone Loss

Periodontitis is the destructive form of periodontal disease, in which inflammation extends beyond the gingiva to cause irreversible loss of the connective tissue attachment and resorption of the alveolar bone that supports the teeth. Unlike gingivitis, the tissue destruction of periodontitis does not reverse with biofilm control, and progressive disease can lead to tooth mobility and loss.

Definition

Periodontitis is a chronic, inflammation-mediated disease of the periodontium in which a dysbiotic biofilm and a dysregulated host response cause irreversible loss of connective tissue attachment and resorption of alveolar bone, characterised clinically by clinical attachment loss and radiographic bone loss.

Scope

This entry covers periodontitis (historically including the category of chronic periodontitis) and its hallmark, alveolar bone loss: the transition from gingival inflammation to attachment loss, the mechanisms of inflammatory bone resorption, the staging-and-grading framework that defines and classifies the disease, and its recognised systemic associations. It is an educational reference describing disease biology and classification, not clinical management.

Core questions

• What converts reversible gingivitis into destructive periodontitis?
• How does inflammation lead to resorption of alveolar bone?
• How is periodontitis defined, staged, and graded?
• Why is periodontitis associated with systemic conditions?

Key concepts

• Clinical attachment loss
• Alveolar bone resorption
• RANKL-mediated osteoclast activation
• Apical migration of junctional epithelium and pocket formation
• Host susceptibility
• Staging and grading
• Periodontal-systemic associations

Mechanisms

Periodontitis develops when the inflammatory response to a dysbiotic subgingival biofilm becomes sustained and dysregulated, extending apically beyond the gingiva. The junctional epithelium migrates apically and a periodontal pocket forms; matrix-degrading enzymes break down the connective tissue attachment, producing clinical attachment loss. Inflammatory mediators shift bone homeostasis toward resorption, with increased osteoclast activity (driven by RANKL and pro-inflammatory cytokines) leading to loss of alveolar bone. The orchestration of this destructive response by host immune and inflammatory cells, rather than the bacteria alone, determines disease severity (Kornman et al., 1997; Hajishengallis, 2015). The 2017 classification frames disease extent and progression through staging and grading (Tonetti et al., 2018).

Clinical relevance

Periodontitis is a leading cause of tooth loss in adults and is recognised as a chronic inflammatory disease with associations to systemic health; understanding its mechanisms and classification supports critical appraisal of the literature. This entry is descriptive and does not provide diagnostic or treatment recommendations for individuals.

Epidemiology

Severe periodontitis is among the most prevalent chronic inflammatory conditions globally, and its burden rises with age and with risk factors such as smoking and diabetes (Kinane et al., 2017).

Evidence & guidelines

The 2017 World Workshop replaced the prior chronic/aggressive distinction with a single category of periodontitis characterised by a multidimensional staging-and-grading system describing severity, extent, and rate of progression (Tonetti et al., 2018). Consensus reports have also examined the association between periodontitis and cardiovascular disease (Sanz et al., 2020).

History

Periodontitis was long described in terms of irritation and infection before the host-response model clarified that inflammation, not bacteria alone, mediates the tissue destruction (Kornman et al., 1997). The 1999 classification distinguished chronic and aggressive forms, but the 2017 World Workshop consolidated these into a single staging-and-graded entity, reflecting evidence that they represent a continuum (Tonetti et al., 2018).

Debates

Chronic versus aggressive periodontitis

The earlier separation of chronic and aggressive periodontitis was replaced in 2017 by a unified periodontitis category with staging and grading, reflecting a view that the two are not biologically distinct diseases; the change remains a notable reframing of how the disease is classified.

Key figures

• Roy Page
• Kenneth Kornman
• Maurizio Tonetti
• George Hajishengallis

Seminal works

• page-kornman-1997
• tonetti-2018
• hajishengallis-2014

Frequently asked questions

Why is bone loss in periodontitis irreversible?

Periodontitis destroys the connective tissue attachment and resorbs alveolar bone through sustained inflammation; unlike gingival inflammation, this lost supporting tissue does not regenerate spontaneously when the biofilm is controlled.

What replaced the term chronic periodontitis?

The 2017 World Workshop merged chronic and aggressive periodontitis into a single category of periodontitis described by a staging-and-grading system rather than separate disease labels.